HomeCompareARGUU vs JNJ

ARGUU vs JNJ: Dividend Comparison 2026

ARGUU yields 19.55% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ARGUU wins by $51.0K in total portfolio value
10 years
ARGUU
ARGUU
● Live price
19.55%
Share price
$10.23
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$71.0K
Annual income
$6,421.32
Full ARGUU calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — ARGUU vs JNJ

📍 ARGUU pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodARGUUJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ARGUU + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ARGUU pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ARGUU
Annual income on $10K today (after 15% tax)
$1,661.78/yr
After 10yr DRIP, annual income (after tax)
$5,458.12/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, ARGUU beats the other by $4,754.51/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ARGUU + JNJ for your $10,000?

ARGUU: 50%JNJ: 50%
100% JNJ50/50100% ARGUU
Portfolio after 10yr
$45.5K
Annual income
$3,624.55/yr
Blended yield
7.96%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

ARGUU
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ARGUU buys
0
JNJ buys
0
No recent congressional trades found for ARGUU or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricARGUUJNJ
Forward yield19.55%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$71.0K$20.0K
Annual income after 10y$6,421.32$827.78
Total dividends collected$39.9K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: ARGUU vs JNJ ($10,000, DRIP)

YearARGUU PortfolioARGUU Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$12,655$1,955.03$10,676$355.77+$2.0KARGUU
2$15,853$2,312.25$11,407$389.39+$4.4KARGUU
3$19,670$2,707.08$12,198$426.53+$7.5KARGUU
4$24,186$3,139.11$13,056$467.62+$11.1KARGUU
5$29,486$3,607.30$13,987$513.12+$15.5KARGUU
6$35,660$4,110.13$14,998$563.56+$20.7KARGUU
7$42,802$4,645.56$16,098$619.52+$26.7KARGUU
8$51,010$5,211.16$17,295$681.69+$33.7KARGUU
9$60,384$5,804.11$18,599$750.82+$41.8KARGUU
10$71,033$6,421.32$20,022$827.78+$51.0KARGUU

ARGUU vs JNJ: Complete Analysis 2026

ARGUUStock

Argus Capital Corp. does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to focus on businesses in the media/entertainment/sports industries. The company was incorporated in 2021 and is based in New York, New York.

Full ARGUU Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this ARGUU vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ARGUU vs SCHDARGUU vs JEPIARGUU vs OARGUU vs KOARGUU vs MAINARGUU vs ABBVARGUU vs MRKARGUU vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.